The Defense Logistics Agency awarded a $239,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The prime contractor will deliver 2.5ml bottles of the glaucoma medication to the DLA under this single day contract ending June 23, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The DLA manages the Department of Defense's global...
The Defense Logistics Agency awarded a $328.88 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 2.5mL bottles of the glaucoma medication to support DLA programs. The firm fixed price order is for performance from August 8-9, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This award draws from DLA's pharmaceutical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $958 to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is to supply 2.5mL of the glaucoma drug to a DLA facility located in Conshohocken, Pennsylvania. Amerisourcebergen will perform as the prime contractor, delivering the pharmaceutical product between July 18-19, 2023. No additional details were provided regarding subcontractors or the context of the requirement...
The Defense Logistics Agency awarded a $41,430 firm fixed price delivery order to Amerisourcebergen Drug Corporation for timolol maleate 0.5% eye drops. As the prime contractor, Amerisourcebergen will supply 15ml bottles of the ophthalmic solution to support DLA needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. The delivery order was issued under DLA's pharmaceuticals distribution vehicle, with no set aside...
The Defense Logistics Agency awarded a $822.20 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is for 2.5ml of the eye drop medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 18, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services. This small order for an ophthalmic...
The Defense Logistics Agency awarded a delivery order valued at $10,963.88 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication commonly used to treat glaucoma and ocular hypertension. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
The Defense Logistics Agency awarded a $441,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is being fulfilled under the prime contractor's corporate office division from its facility in Conshohocken, Pennsylvania. The solution will support DLA's medical supply needs from August 3rd to August 4th, 2023. No set aside designation or subcontractors were indicated. DLA manages the global supply chain for the United States...
The Defense Logistics Agency awarded a $493 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is to supply 2.5mL of the glaucoma drug to a DLA facility in Conshohocken, Pennsylvania, with performance from August 31st to September 1st, 2023. Amerisourcebergen will deliver the requested pharmaceutical product to the Defense Logistics Agency, the Department of Defense's combat logistics support agency, in support of its...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,330.21, is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat certain types of glaucoma and high eye pressure. The contract has a period of performance through December 9, 2024 and is a firm fixed-price contract....
The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...